Contact us
We understand the urgency of accessing treatments for rare diseases and kindly ask that you review our Compassionate Use Policy for details of our process and how to submit a request
Latest news and articles
News & Opinion
Jonathan Milner, Ph.D., Appointed as Non-Executive Chairman of Healx
News & Opinion
Healx announces agreement with Sanofi to seek new rare disease indications for compound using AI drug discovery platform
News & Opinion
U.S. FDA Grants Fast Track designation for HLX-1502 in Neurofibromatosis Type 1 (NF1) Treatment